Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00076544
Status:
COMPLETED
Last Update Posted:
2015-12-14
First Post:
2004-01-26
Brief Title:
Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
Sponsor:
Elan Pharmaceuticals
Organization:
Elan Pharmaceuticals
Study Overview
Official Title:
An Open-Label Long-Term Multi-Center Intrathecal Ziconotide PRIALT Effectiveness and Safety Trial ZEST in Patients With Chronic Severe Pain
Status:
COMPLETED
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this open-label study is to give chronic severe pain patients with existing intrathecal pump systems access to ziconotide
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None